+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Induced Pluripotent Stem Cell (iPSC) Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change

  • ID: 5414899
  • Report
  • August 2021
  • Region: Global
  • 268 pages
  • The Business Research Company

FEATURED COMPANIES

  • Fate Therapeutics
  • Takara Bio Inc.
  • ViaCyte
  • MORE

This report provides the strategists, marketers and senior management with the critical information they need to assess the global induced pluripotent stem cell (iPSC) market as it emerges from the COVID-19 shut-down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:

Where is the largest and fastest growing market for induced pluripotent stem cell (iPSC)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The induced pluripotent stem cell (iPSC) market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider induced pluripotent stem cell (iPSC) market, and compares it with other markets.

The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure - This section gives the structure of the report and the information covered in various sections.
  • Introduction - This section gives the segmentation of the induced pluripotent stem cell (iPSC) market by geography, segmentation by derived cell type, by application, by end-user.
  • Market Characteristics - The market characteristics section of the report defines and explains the induced pluripotent stem cell (iPSC) market. This chapter includes different products and services covered in the report and basic definitions.
  • Trends and Strategies - This chapter includes some of the major trends shaping the global induced pluripotent stem cell (iPSC) market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 - This chapter describes the impact of COVID-19 on the induced pluripotent stem cell (iPSC) industry.
  • Global Market Size and Growth - This section contains the global historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis - This section contains the historic (2015-2020) and forecast (2020-2025), and (2025-2030) market values and growth and market share comparison by region.
  • Segmentation - This section contains the market value (2015-2030) and analysis for different segments.
  • Regional Market Size and Growth - This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025) and (2025-2030) market values, and growth and market share comparison of major countries within the region. This section includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.
  • Competitive Landscape - This section covers details on the competitive landscape of the global induced pluripotent stem cell (iPSC) market, estimated market shares and company profiles for the leading players.
  • Key Mergers and Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities and Strategies - This section includes market opportunities and strategies based on the findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions and Recommendations - This section includes conclusions and recommendations based on the findings of the research. This section also gives recommendations for induced pluripotent stem cell (iPSC) companies in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  1. By Derived Cell Type: Hepatocytes; Fibroblasts; Keratinocytes; Amniotic; Others
  2. By Application: Academic Research; Drug Discovery and Toxicity Studies; Regenerative Medicine; Gene & Cell Therapy
  3. By End-User: Hospitals; Research Laboratories

Companies Mentioned:

Fujifilm Holding Corporation; Thermo Fisher Scientific Inc.; Takara Bio Inc.; ViaCyte; Fate Therapeutics

Countries:

Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions:

Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series:

Five years historic and ten years forecast.

Data:

Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, induced pluripotent stem cell (iPSC) indicators comparison.

Data Segmentations:

Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing:

Data and analysis throughout the report is sourced using end notes.

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Fate Therapeutics
  • Takara Bio Inc.
  • ViaCyte
  • MORE
1. Induced Pluripotent Stem Cell (iPSC) Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Derived Cell Type
6.3. Segmentation By Application
6.4. Segmentation By End-Use Industry

7. Induced Pluripotent Stem Cell (iPSC) Market Characteristics
7.1. Segmentation By Derived Cell Type
7.1.1. Hepatocytes
7.1.2. Fibroblasts
7.1.3. Keratinocytes
7.1.4. Amniotic
7.1.5. Others
7.2. Segmentation By Application
7.2.1. Academic Research
7.2.2. Drug Discovery Toxicity Studies
7.2.3. Regenerative Medicine
7.2.4. Gene & Cell Therapy
7.3. Segmentation By End-User
7.3.1. Hospitals
7.3.2. Research Laboratories

8. Induced Pluripotent Stem Cell (iPSC) Trends Strategies
8.1. Use of Pluripotent Stem Cells in treating Parkinson’s Disease (PD)
8.2. Strategic Collaborations Partnerships
8.3. Development Of Induced Pluripotent Stem Cell iPSC-Derived NK Cells
8.4. Demand For Induced Pluripotent Stem Cell (iPSC) For Cell Therapy
8.5. Expansion and Improvements in Drug Research
8.6. Use of Pluripotent Stem Cells in treating Type 1 Diabetes

9. Impact Of Covid-19 On Induced Pluripotent Stem Cell (iPSC) Market
9.1. Impact On Demand For Induced Pluripotent Stem Cells
9.2. Increase In Research Development Activities

10. Global Induced Pluripotent Stem Cell (iPSC) Size Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 - 2020
10.2.2. Restraints On The Market 2015 - 2020
10.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
10.3.1. Drivers Of The Market 2020 - 2025
10.3.2. Restraints On The Market 2020 - 2025

11. Global Induced Pluripotent Stem Cell (iPSC) Segmentation
11.1. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Derived Cell Type , Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.1.1. Fibroblasts
11.1.2. Hepatocytes
11.1.3. Keratinocytes
11.1.4. Amniotic
11.1.5. Others
11.2. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.2.1. Drug Discovery & Toxicity Studies
11.2.2. Academic Research
11.2.3. Cell & Gene Therapy
11.2.4. Regenerative Medicine
11.3. Global Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.3.1. Research Laboratories
11.3.2. Hospitals

12. Induced Pluripotent Stem Cell (iPSC) Market, Regional Country Analysis
12.1. Global Induced Pluripotent Stem Cell (iPSC) Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Induced Pluripotent Stem Cell (iPSC) Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

13. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market
13.1. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. Impact of COVID-19
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax Structure
13.1.11. Investments
13.1.12. Major Companies
13.2. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.4. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application , Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.5. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.6. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
13.7. China Induced Pluripotent Stem Cell (iPSC) Market
13.8. China Induced Pluripotent Stem Cell (iPSC) Market Overview
13.8.1. Country Information
13.8.2. Market Information
13.8.3. Impact of COVID-19
13.8.4. Background Information
13.8.5. Government Initiatives
13.8.6. Regulations
13.8.7. Regulatory Bodies
13.8.8. Major Associations
13.8.9. Taxes Levied
13.8.10. Corporate Tax Structure
13.8.11. Investments
13.8.12. Major Companies
13.9. China Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.10. China Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.11. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.12. China Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.13. India Induced Pluripotent Stem Cell (iPSC) Market
13.14. India Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.15. India Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.16. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.17. India Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.18. Japan Induced Pluripotent Stem Cell (iPSC) Market
13.19. Japan Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.20. Japan Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.21. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.22. Japan Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.23. Australia Induced Pluripotent Stem Cell (iPSC) Market
13.24. Australia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.25. Australia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.26. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.27. Australia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.28. Indonesia Induced Pluripotent Stem Cell (iPSC) Market
13.29. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.30. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.31. Indonesia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.32. South Korea Induced Pluripotent Stem Cell (iPSC) Market
13.33. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.34. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.35. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.36. South Korea Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Induced Pluripotent Stem Cell (iPSC) Market
14.1. Western Europe Induced Pluripotent Stem Cell (iPSC) Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. Impact Of COVID-19
14.1.4. Background Information
14.1.5. Government Initiatives
14.1.6. Regulations
14.1.7. Regulatory Bodies
14.1.8. Major Associations
14.1.9. Taxes Levied
14.1.10. Corporate Tax Structure
14.1.11. Investments
14.1.12. Major Companies
14.2. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.3. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.4. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.6. Western Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
14.7. UK Induced Pluripotent Stem Cell (iPSC) Market
14.8. UK Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.9. UK Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.10. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.11. UK Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.12. Germany Induced Pluripotent Stem Cell (iPSC) Market
14.13. Germany Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.14. Germany Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.15. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.16. Germany Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.17. France Induced Pluripotent Stem Cell (iPSC) Market
14.18. France Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.19. France Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.20. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.21. France Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market
15.1. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. Impact Of COVID-19
15.1.4. Background information
15.1.5. Government Initiatives
15.1.6. Regulations
15.1.7. Regulatory bodies
15.1.8. Major Associations
15.1.9. Taxes levied
15.1.10. Corporate tax structure
15.1.11. Investments
15.1.12. Major Companies
15.2. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.3. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.4. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.5. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
15.7. Russia Induced Pluripotent Stem Cell (iPSC) Market
15.8. Russia Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.9. Russia Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.10. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.11. Russia Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America Induced Pluripotent Stem Cell (iPSC) Market
16.1. North America Induced Pluripotent Stem Cell (iPSC) Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. COVID-19 Impact
16.1.4. Background Information
16.1.5. Government Initiatives
16.1.6. Regulations
16.1.7. Regulatory Bodies
16.1.8. Associations
16.1.9. Taxes Levied
16.1.10. Corporate Tax Structure
16.1.11. Investments
16.1.12. Major Companies
16.2. North America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.3. North America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.4. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
16.7. USA Induced Pluripotent Stem Cell (iPSC) Market
16.8. USA Induced Pluripotent Stem Cell (iPSC) Market Overview
16.8.1. Country Information
16.8.2. Market Information
16.8.3. COVID-19 Impact
16.8.4. Background Information
16.8.5. Government Initiatives
16.8.6. Regulations
16.8.7. Regulatory Bodies
16.8.8. Associations
16.8.9. Taxes Levied
16.8.10. Corporate Tax Structure
16.8.11. Investments
16.8.12. Major Companies
16.9. USA Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.10. USA Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.11. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America Induced Pluripotent Stem Cell (iPSC) Market
17.1. South America Induced Pluripotent Stem Cell (iPSC) Market Overview
17.1.1. Region Information
17.1.2. Market Information
17.1.3. COVID-19 Impact
17.1.4. Background Information
17.1.5. Government Initiatives
17.1.6. Regulations
17.1.7. Regulatory Bodies
17.1.8. Associations
17.1.9. Taxes Levied
17.1.10. Corporate Tax Structure
17.1.11. Investments
17.1.12. Major Companies
17.2. South America Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.3. South America Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.4. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.6. South America Induced Pluripotent Stem Cell (iPSC) Market: Country Analysis
17.7. Brazil Induced Pluripotent Stem Cell (iPSC) Market
17.8. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.9. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.10. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.11. Brazil Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Induced Pluripotent Stem Cell (iPSC) Market
18.1. Middle East Induced Pluripotent Stem Cell (iPSC) Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. COVID-19 Impact
18.1.4. Background information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory bodies
18.1.8. Major Associations
18.1.9. Taxes levied
18.1.10. Corporate tax structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.3. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.4. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa Induced Pluripotent Stem Cell (iPSC) Market
19.1. Africa Induced Pluripotent Stem Cell (iPSC) Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory bodies
19.1.8. Major Associations
19.1.9. Taxes levied
19.1.10. Corporate tax structure
19.1.11. Investments
19.1.12. Major Companies
19.2. Africa Induced Pluripotent Stem Cell (iPSC) Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
19.3. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By Application, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.4. Africa Induced Pluripotent Stem Cell (iPSC) Market, Segmentation By End-Use Industry, Historic Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global Induced Pluripotent Stem Cell (iPSC) Competitive Landscape
20.1. Company Profiles
20.2. Fujifilm Holdings Corporation
20.2.1. Company Overview
20.2.2. Products Services
20.2.3. Business Strategy
20.2.4. Financial Overview
20.3. Thermo Fisher Scientific Inc.
20.3.1. Company Overview
20.3.2. Products Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Takara Bio Inc.
20.4.1. Company Overview
20.4.2. Products Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. ViaCyte
20.5.1. Company Overview
20.5.2. Products Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Fate Therapeutics
20.6.1. Company Overview
20.6.2. Products Services
20.6.3. Business Strategy
20.6.4. Financial overview

21. Key Mergers Acquisitions In The Induced Pluripotent Stem Cell (iPSC) Market
21.1. Axol Bioscience Mergerd With Censo Biotechnologies
21.2. FUJIFILM Cellular Dynamics Merged with Sana Biotechnology
21.3. FUJIFILM Cellular Dynamics Collaborated With Lonza Walkersville, Inc.
21.4. Insitro, Inc. Collaborated With Bristol Myers Squibb
21.5. Century Therapeutics Acquired of Empirica Therapeutics
21.6. Fate Therapeutics Collaborated With Janssen
21.7. Bristol-Myers Squibb Company Collaborated With Evotech
21.8. Allogene Therapeutics Merged with Notch Therapeutics
21.9. Bayer Acquired BlueRock Therapeutics
21.10. Evotech Acquired NCARDIA
21.11. Evotec AG Merged with Celgene
21.12. Pluriomics and Axiogenesis Merged to establish Ncardia

22. Induced Pluripotent Stem Cell (iPSC) Market Opportunities Strategies
22.1. Global Induced Pluripotent Stem Cell (iPSC) In 2025 - Countries Offering Most New Opportunities
22.2. Global Induced Pluripotent Stem Cell (iPSC) In 2025 - Segments Offering Most New Opportunities
22.3. Global Induced Pluripotent Stem Cell (iPSC) Market In 2025 - Growth Strategies
22.3.1. Market Trend Based Strategies
22.3.2. Competitor Strategies

23. Induced Pluripotent Stem Cell (iPSC) Market, Conclusions Recommendations
23.1. Conclusions
23.2. Recommendations
23.2.1. Product
23.2.2. Place
23.2.3. Price
23.2.4. Promotion
23.2.5. People

24. Appendix
24.1. Market Data Sources
24.2. Research Methodology
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher
24.6. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Fate Therapeutics
  • Takara Bio Inc.
  • ViaCyte
  • MORE
This report describes and explains the induced pluripotent stem cell (iPSC) market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.

The global induced pluripotent stem cell (iPSC) market reached a value of nearly $2,223.5 million in 2020, having increased at a compound annual growth rate (CAGR) of 9.2% since 2015. The market is expected to grow from $2,223.5 million in 2020 to $3,362.1 million in 2025 at a rate of 8.6%. The market is then expected to grow at a CAGR of 6.2% from 2025 and reach $4,547.7 million in 2030.

Growth in the historic period resulted from increased healthcare spending, rise in funding, aid as non - animal alternatives for preclinical trials and increasing demand of personalized medicines. Factor that negatively affected growth in the historic period was lack of awareness on induced pluripotent stem cell.

Going forward, increasing prevalence of chronic diseases, growth genomic projects, development in iPSC models, increasing funding and increasing prevalence of genetic diseases. Factors that could hinder the growth of the induced pluripotent stem cell (iPSC) market in the future include risk associated with it and high costs associated with storage.

The induced pluripotent stem cell (iPSC) market is segmented by application into drug discovery and toxicity studies, academic research, cell & gene therapy, and regenerative medicine. The drug discovery and toxicity studies was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by application, accounting for 48.7% of the total in 2020. Going forward, cell & gene therapy segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by application, at a CAGR of 9.82% during 2020-2025.

The induced pluripotent stem cell (iPSC) market is also segmented by end-user into hospitals and research laboratories. The research laboratories was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by end-user, accounting for 68.5% of the total in 2020. Going forward, the hospitals segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by end-user, at a CAGR of 9.3% during 2020-2025.

The induced pluripotent stem cell (iPSC) market is also segmented by derived cell type into amniotic, hepatocytes, fibroblasts, keratinocytes and others. The fibroblasts was the largest segment of the induced pluripotent stem cell (iPSC) market segmented by derived cell type, accounting for 33.0% of the total in 2020. Going forward, the others segment is expected to be the fastest growing segment in the induced pluripotent stem cell (iPSC) market segmented by derived cell type, at a CAGR of 10.0% during 2020-2025.

North America was the largest region in the induced pluripotent stem cell (iPSC) market, accounting for 49.8% of the total in 2020. It was followed by Western Europe, and then the other regions. Going forward, the fastest-growing regions in the induced pluripotent stem cell (iPSC) market will be Africa and Asia- Pacific, where growth will be at CAGRs of 15.7% and 15.4% respectively. These will be followed by South America, and Middle East where the markets are expected to grow at CAGRs of 13.7% and 12.4% respectively.

The induced pluripotent stem cell (iPSC) market is fragmented, with a large number of players constituting the market. The top ten competitors in the market made up to 26% of the total market in 2020. Major players in the market include Fujifilm Holding Corporation, Thermo Fisher Scientific Inc Takara Bio Inc., ViaCyte, and Fate Therapeutics.

The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by derived cell type will arise in the fibroblasts segment, which will gain $360.1 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by end-user industry will arise in the hospitals segment, which will gain $393.0 million of global annual sales by 2025. The top opportunities in the induced pluripotent stem cell (iPSC) market segmented by application will arise in the drug discovery and toxicity studies segment, which will gain $520.3 million of global annual sales by 2025. The induced pluripotent stem cell (iPSC) market size will gain the most in the USA at $132.6 million.

Market-trend-based strategies for the induced pluripotent stem cell (iPSC) market include investing in iPSC’s for treating Parkinson’s disease, investing in strategic collaborations, focus on solutions for treating diabetes. Player-adopted strategies in the induced pluripotent stem cell (iPSC) market include expanding existing product portfolio and investing in strategic collaborations and acquisitions to strengthening the business.

To take advantage of these opportunities, the publisher recommends the induced pluripotent and stem cell companies to consider investing in induced pluripotent stem cells, which have proved to be efficient in various diseases for disease modelling and gene therapy, and focus on the acquisitions of mid-size and small companies which are technologically advanced to help increase production capacity and expand product portfolio, focus on securing long-term supply contracts with significant healthcare institutions to provide the patients with quality products, companies should consider offering value-based pricing for their induced pluripotent stem cells, as stakeholders would want to evaluate both the short- and long-term benefits of the product’s value, while hospitals and surgeons focus on the quality and features of the system and after-sales services, companies should expand their business in emerging markets to increase awareness in emerging markets which results in increasing demand for induced pluripotent stem cells, among other strategies.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Fujifilm Holding Corporation
  • Thermo Fisher Scientific Inc.
  • Takara Bio Inc.
  • ViaCyte
  • Fate Therapeutics
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll